SCHEMBL8376830

SCHEMBL8376830

[O]C(Cl)(Cl)c1cccc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 2/20 0.45
CYP2A6 P11509 4/20 0.44
CYP1A2 P05177 3/20 0.44
ALDH1A1 P00352 5/20 0.42
HSD17B10 Q99714 4/20 0.42
TSHR P16473 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
PAX8 Q06710 1/20 0.41
HPGD P15428 2/20 0.39
CYP3A4 P08684 1/20 0.39
KEAP1 Q14145 1/20 0.39
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPRT1 P00492 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1538546 0.81 CYP2A6 (0.54) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL17502201 0.81 ALDH1A1 (0.46) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL18242690 0.79 ALDH1A1 (0.39) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL16933751 0.77 CYP2A6 (0.44) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL8377365 0.77 ALDH1A1 (0.44) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL17966497 0.77 CYP2A6 (0.44) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL11023073 0.77 CYP2A6 (0.44) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL11844876 0.77 CYP2A6 (0.44) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL8376250 0.77 KDM4E (0.46) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL17966537 0.77 CYP1A2 (0.44) ACP3CYP2A6CYP1A2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed